Literature DB >> 11747298

Dietary effects of bitter gourd oil on blood and liver lipids of rats.

R Noguchi1, Y Yasui, R Suzuki, M Hosokawa, K Fukunaga, K Miyashita.   

Abstract

Bitter gourd is widely used as an edible plant in Asia. In this study, we evaluated the effects of bitter gourd oil (BGO) on the blood and liver lipids of rats. Three groups of rats were given a basal diet (AIN-93G) containing 7% fat by weight. The dietary fat consisted of soybean oil (control), soybean oil + BGO (6.5:0.5, w/w; 0.5% BGO), or soybean oil + BGO (5:2, w/w; 2.0% BGO). This fat treatment gave 3.4 and 15.4% of cis(c)9,trans(t)11,t13-18:3 in the dietary fat of 0.5 and 2.0% BGO, respectively. Fatty acid analysis showed the occurrence of c9,t11-18:2 in the liver of rats fed BGO diets, whereas this conjugated linoleic acid (CLA) isomer was not detected in the liver of rats fed the control diet. Furthermore, dietary BGO decreased the concentration of 18:2n-6 and increased the concentration of 22:6n-3. The formation of the CLA isomer in the liver lipids of rats fed BGO diets could be explained by either of the following two metabolic pathways, namely, enzymatic biohydrogenation of c9,t11,t13-18:3 or enzymatic isomerization of c9,c12-18:2. The BGO diets had significantly reduced free cholesterol levels with a trend toward an increase in HDL cholesterol, but there was no significant change in the total cholesterol. The dietary BGO also affected the level of plasma hydroperoxides. A slight but significant increase in hydroperoxides was found in the rats fed 2.0% BGO. This may be attributed to the lower oxidative stability of c9,t11,t13-18:3 in BGO. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747298     DOI: 10.1006/abbi.2001.2624

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Comparative study of hypocholesterolemic and hypolipidemic effects of conjugated linolenic acid isomers against induced biochemical perturbations and aberration in erythrocyte membrane fluidity.

Authors:  Siddhartha S Saha; Anirban Chakraborty; Santinath Ghosh; Mahua Ghosh
Journal:  Eur J Nutr       Date:  2011-08-04       Impact factor: 5.614

2.  Dietary conjugated α-linolenic acid did not improve glucose tolerance in a neonatal pig model.

Authors:  Christian-Alexandre Castellano; Jean-Patrice Baillargeon; Mélanie Plourde; Sandie I Briand; Paul Angers; Alain Giguère; J Jacques Matte
Journal:  Eur J Nutr       Date:  2013-09-05       Impact factor: 5.614

Review 3.  Cancer chemopreventive ability of conjugated linolenic acids.

Authors:  Takuji Tanaka; Masashi Hosokawa; Yumiko Yasui; Rikako Ishigamori; Kazuo Miyashita
Journal:  Int J Mol Sci       Date:  2011-11-02       Impact factor: 5.923

Review 4.  The Role of Momordica charantia in Resisting Obesity.

Authors:  Meiqi Fan; Eun-Kyung Kim; Young-Jin Choi; Yujiao Tang; Sang-Ho Moon
Journal:  Int J Environ Res Public Health       Date:  2019-09-04       Impact factor: 3.390

5.  Effect of Bitter Melon on Spatial Memory of Rats Receiving a High-Fat Diet.

Authors:  Hamid Sepehri; Arefeh Hojati; Razieh Safari
Journal:  J Exp Pharmacol       Date:  2019-12-10

6.  Essential Oils Derived from Momordica charantia Seeds Exhibited Antiulcer Activity against Hydrogen Chloride/Ethanol and Indomethacin.

Authors:  Nurul 'Ain Abu Bakar; Muhammad Nazrul Hakim Abdullah; Vuanghao Lim; Yoke Keong Yong
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-22       Impact factor: 2.629

Review 7.  Uncommon Fatty Acids and Cardiometabolic Health.

Authors:  Kelei Li; Andrew J Sinclair; Feng Zhao; Duo Li
Journal:  Nutrients       Date:  2018-10-20       Impact factor: 5.717

8.  In vitro anti-diabetic activities and chemical analysis of polypeptide-k and oil isolated from seeds of Momordica charantia (bitter gourd).

Authors:  Zuraini Ahmad; Khairul Faizi Zamhuri; Azhar Yaacob; Chiong Hoe Siong; Malarvili Selvarajah; Amin Ismail; Muhammad Nazrul Hakim
Journal:  Molecules       Date:  2012-08-10       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.